PAR 13.7% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-205

  1. 286 Posts.
    lightbulb Created with Sketch. 79

    looks like there are multiple companies in multiple regions for both OA and MPS that have signed non binding agreements.

    we don’t know if this is actually true or not but it’s what Beverley Huttman said in the AGM and it may explain Paul’s continual references to imminent deals over the last 12 months (that haven’t materialised).

    I would also say, any pharmaceutical company that is active in replenishing their product line would be aware of our 005 008 phase2b results by now. Brilliant data…. We need 80
    mill USD to get through 1st component of the second part of the phase 3 before applying for accelerated approval

    Paul knows acutely well that we need deals to save his job, career and dignity. I reckon he has something to announce shortly but what do I know? Fek all!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.035(13.7%)
Mkt cap ! $101.4M
Open High Low Value Volume
25.5¢ 29.0¢ 25.0¢ $162.3K 595.5K

Buyers (Bids)

No. Vol. Price($)
2 49897 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 24504 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.